NO942756L - Behandling av glaucoma - Google Patents

Behandling av glaucoma

Info

Publication number
NO942756L
NO942756L NO942756A NO942756A NO942756L NO 942756 L NO942756 L NO 942756L NO 942756 A NO942756 A NO 942756A NO 942756 A NO942756 A NO 942756A NO 942756 L NO942756 L NO 942756L
Authority
NO
Norway
Prior art keywords
treatment
glaucoma
retinal
eye
salts
Prior art date
Application number
NO942756A
Other languages
English (en)
Other versions
NO942756D0 (no
Inventor
William Cash
Georg Mathis
Marc De Gasparo
Original Assignee
Ciba Vision Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Vision Ag filed Critical Ciba Vision Ag
Publication of NO942756D0 publication Critical patent/NO942756D0/no
Publication of NO942756L publication Critical patent/NO942756L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Det blir beskrevet anvendelsen av forbindelser med formel (I), \ (D, hvor er -CH (la) eller X er CH CH3 CH T ----CH---- (lb ), karboksy gruppen er direkte bundet til cyklopentylrlngen l det tilfellet hvor X = (la) og deres salter, ved fremstil- lingen av .farmasøytiske sammensetninger for behandling av glaucoma, for økning av bevegelsen av (retlnalt) intra-okulart fluid, for behandling av vasospastlske tilstander i øyet og for behandling . av diabetisk retlnopatl og også tilsvarende oftalmiske sammen-setninger.
NO942756A 1992-02-17 1994-07-22 Behandling av glaucoma NO942756L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH45992 1992-02-17
PCT/US1993/001431 WO1993015732A1 (en) 1992-02-17 1993-02-17 Treatment of glaucoma

Publications (2)

Publication Number Publication Date
NO942756D0 NO942756D0 (no) 1994-07-22
NO942756L true NO942756L (no) 1994-07-22

Family

ID=4187501

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942756A NO942756L (no) 1992-02-17 1994-07-22 Behandling av glaucoma

Country Status (8)

Country Link
EP (1) EP0626846A1 (no)
JP (1) JPH07504099A (no)
AU (1) AU3722493A (no)
CA (1) CA2128324A1 (no)
IL (1) IL104755A0 (no)
NO (1) NO942756L (no)
WO (1) WO1993015732A1 (no)
ZA (1) ZA931063B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2181461A1 (en) * 1994-02-08 1995-08-17 Alica Huxley Treatment of normotensive glaucoma with angiotensin ii antagonists
SK117996A3 (en) * 1994-03-17 1997-03-05 Ciba Geigy Ag Pharmaceutical composition for treatment of diabetic nephropathy
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
EP1459743B9 (en) 1998-08-17 2012-08-01 Senju Pharmaceutical Co., Ltd. Agent for prophylaxis and treatment of glaucoma
EP1112749A4 (en) * 1998-08-20 2004-06-16 Senju Pharma Co PROPHYLAXIS OR REMEDIES FOR CIRCULATORY EYE DISTURBANCE
EP1197223B1 (en) 1999-04-28 2005-02-16 Takeda Pharmaceutical Company Limited Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
FR2878522B1 (fr) * 2004-12-01 2008-04-18 Merck Sante Soc Par Actions Si Nouveaux inhibiteurs specifiques de la caspas-10

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036048A (en) * 1986-03-07 1991-07-30 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
DK0443983T3 (da) * 1990-02-19 1996-03-18 Ciba Geigy Ag Acrylforbindelser
TW201738B (no) * 1990-03-20 1993-03-11 Sanofi Co
FR2672891B1 (fr) * 1991-02-20 1994-02-18 Synthelabo Derives de 3-pyrazolones, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
EP0626846A1 (en) 1994-12-07
AU3722493A (en) 1993-09-03
CA2128324A1 (en) 1993-08-19
NO942756D0 (no) 1994-07-22
WO1993015732A1 (en) 1993-08-19
JPH07504099A (ja) 1995-05-11
IL104755A0 (en) 1993-06-10
ZA931063B (en) 1993-09-23

Similar Documents

Publication Publication Date Title
ES476496A1 (es) Procedimiento para preparar derivados de acido ftalazin-4- ilacetico.
EP1225168B8 (en) Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension
ES8705886A1 (es) Un metodo para preparar un derivadode tiazolidin-diona
AR040806A1 (es) Derivados de piperidi-2-ona 1,6 disustituidos, composicion farmaceutica que la comprende y metodo de tratamiento
NO942756L (no) Behandling av glaucoma
ATE104145T1 (de) 4-substituierten imidazolen zur senkung des intraokularen druckes.
MXPA05011125A (es) Remedio preventivo para enfermedades del nervio retiniano que contienen derivados de eter de alquilo o sales de los mismos.
CA2081113A1 (en) Thiazolidine-2,4-dione derivative, salt thereof, and production of the same
FI881104A0 (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
NO873722D0 (no) Nye derivater av 4,5-dihydro-oksazoler, samt fremgangsmaate for deres fremstilling.
EP0420606A3 (en) Use of 2-cycloalkylamino oxazolines for reducing or maintaining intraocular pressure
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
KR960003719A (ko) 녹내장 치료제 및 안압 강하제
AU6291494A (en) Benzothiazole compound, process for producing the same, and use thereof
NO941932L (no) Nye [1-(1H-imidazol-4-yl)-alkylÅ-benzenderivater, fremgangsmåte ved deres fremstilling og öyepreparater inneholdende dem som aktiv bestanddel
NO20020475D0 (no) 2-aminotetralinderivater for terapi av glaukom
EP0020765A4 (fr) Remede contre le glaucome.
AU6101890A (en) Therapeutic agents for the treatment of peptic ulcer disease
JPS55102516A (en) Remedy for glaucoma
IE791205L (en) Novel oxothia compounds, processes for their preparation,¹pharmaceutical preparations containing these compounds and¹such compounds for therapeutic use
ES462982A1 (es) Un procedimiento para la preparacion de un derivado de acido 8-azaprostanoico.
EP1300150A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension